What are the treatment options for pain control and spasticity management in a patient with syringomyelia who is allergic to opioids (narcotic pain relievers)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pain Control for Syringomyelia with Opioid Allergy

For patients with syringomyelia who are allergic to opioids, first-line treatment should include anticonvulsants (gabapentin or pregabalin) combined with muscle relaxants (tizanidine or baclofen) for effective management of both neuropathic pain and spasticity. 1

First-Line Medications

Anticonvulsants for Neuropathic Pain

  • Gabapentin: Start at 300mg daily and titrate up to 1200-3600mg/day in divided doses
  • Pregabalin: Start at 75mg twice daily and titrate up to 300-600mg/day in divided doses

These medications are considered first-line for neuropathic pain management in syringomyelia due to their ability to bind to calcium channels in the brain and spinal cord, inhibiting the release of excitatory neurotransmitters involved in pain transmission 1. Common side effects include somnolence, dizziness, and weight gain.

Muscle Relaxants for Spasticity

  • Tizanidine: 2-4mg every 6-8 hours as needed (maximum 36mg/day)

    • Short-acting and particularly useful for times when relief of spasticity is most important 2
    • Monitor for sedation, hypotension, and dry mouth
  • Baclofen: Start at 5mg three times daily, gradually increase to 20-25mg three times daily as needed

    • Effective for spasticity management but requires careful monitoring for sedation 3
    • Avoid abrupt discontinuation due to risk of withdrawal symptoms

Second-Line Treatments

Antidepressants

  • Tricyclic antidepressants (amitriptyline, nortriptyline): 10-25mg at bedtime, gradually increasing to 50-150mg
  • SNRIs (duloxetine, milnacipran): Duloxetine 30-60mg daily or milnacipran 50-100mg twice daily

These medications enhance monoaminergic neurotransmission and have strong evidence for analgesic effects in neuropathic pain 1. TCAs should be used cautiously in patients with cardiovascular disease due to potential side effects.

Topical Analgesics

For localized pain areas:

  • Lidocaine patches: Apply to painful area for 12 hours on/12 hours off
  • Capsaicin: Apply to affected area (start with low concentration)

Advanced Interventions for Refractory Pain

Interventional Procedures

If pain remains inadequately controlled with medication management:

  • Intrathecal baclofen: Consider for severe spasticity that contributes to pain 1
  • Neurosurgical procedures: Selective dorsal rhizotomy or dorsal root entry zone lesions may be considered for severe, refractory spasticity causing pain 1

Surgical Management

For patients with progressive neurological deterioration or pain unresponsive to medical management:

  • Syringoperitoneal shunting: Has shown favorable results in alleviating pain (100% effectiveness in one study) 4
  • Surgical correction of underlying causes: Particularly important if there are craniocervical junction abnormalities 5

Comprehensive Approach

Non-Pharmacological Interventions

  • Physical therapy: Range-of-motion exercises, heat/cold application
  • Cognitive behavioral therapy: For pain coping strategies
  • Splinting: For management of spasticity-related contractures

Monitoring and Follow-up

  • Assess pain control using validated pain scales
  • Monitor for medication side effects, particularly sedation and cognitive impairment
  • Regular MRI follow-up to assess syrinx progression

Important Considerations and Pitfalls

  1. Avoid benzodiazepines: Guidelines specifically recommend against using diazepam or other benzodiazepines during stroke recovery due to potential deleterious effects on recovery and sedation 1

  2. Medication timing: For spasticity management, schedule medication doses to coincide with times when spasticity relief is most needed 2

  3. Sedation risk: Many effective medications for neuropathic pain and spasticity cause sedation. Monitor closely and consider morning-only dosing of stimulating medications if needed 1

  4. Early intervention: Better outcomes are observed in patients with less severe neurological deficits, suggesting the need for early treatment 4

  5. Combination therapy: Using multiple medication classes with different mechanisms of action often provides better pain control than monotherapy at higher doses

The treatment of syringomyelia-related pain remains challenging, but a systematic approach using anticonvulsants and muscle relaxants as first-line therapy, followed by appropriate adjuvant medications and interventional procedures when necessary, can provide significant pain relief and improved quality of life for these patients.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.